Overview

Update
IPO / Stock
Went Public on Jan 1, 2014 / OTCBB:ENUM
Total Equity Funding
$7.81M in 4 Rounds
Headquarters:
New York, NY
Description:
Enumeral Biomedical uses a nanotechnology-enabled process for therapeutic discovery, immune profiling and personalized medicine.
Founders:
Categories:
Therapeutics, Biotechnology, Nanotechnology
Website:
http://enumeral.com

Funding Rounds (7) - $32.98M

Update
DateAmount / RoundValuationLead InvestorInvestors
Aug, 2016$3.04M / Post Ipo Debt0
Aug, 2014$21.5M / Post Ipo Equity2
May, 2014$2.02M / Venture0
Feb, 2014$635k / Debt Financing0
May, 2013$1.52M / Private Equity0
Jul, 2012$2.27M / Venture0
May, 2011$2M / Series A0

Board Members and Advisors (2)

Update

News (7)

Update
DateNews
Jul 28, 2016SEC - UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Aug 4, 2014Business Wire - Enumeral Biomedical Raises $21.5 Million from New and Current Investors, Begins Public Trading
May 7, 2014SEC - SEC
Feb 11, 2014SEC - SEC FORM D
Aug 7, 2013SEC - SEC FORM D
May 27, 2013SEC - SEC FORM D
May 21, 2011SEC - SEC FORM D

Offices/Locations (1)

Update
  • Office

    1450 Broadway

    24th Floor

    New York, NY 10018

    USA

Past Team (1)

Update

Add Acquisitions

Add Current Team

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Images

Add Videos